Clinical Trial

Point of Care Tests in the Management of Very Early Medical Abortion

Study acronym: POCT VEMA
Recruiting
View on ClinicalTrials.gov →
Summary
This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-10; most recent amendment 2026-06-01.
Trial Details
NCT Number NCT07417787
Lead Sponsor University of Edinburgh
Collaborators: NORDIC pharma (funding), NHS Lothian, Karolinska Institutet, Karolinska University Hospital, Göteborg University, Sahlgrenska University Hospital
Conditions Abortion Early
Enrollment 130 participants
Start Date 2026-04-23
Primary Completion 2027-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-03